IVERIC Financial Statements From 2010 to 2024
| ISEEDelisted Stock | USD 39.95 0.00 0.00% |
Check IVERIC Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IVERIC Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . IVERIC financial statements analysis is a perfect complement when working with IVERIC Bio Valuation or Volatility modules.
IVERIC |
IVERIC Bio Company Current Valuation Analysis
IVERIC Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current IVERIC Bio Current Valuation | 4.98 B |
Most of IVERIC Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IVERIC Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, IVERIC Bio has a Current Valuation of 4.98 B. This is 65.32% lower than that of the Biotechnology sector and 7.24% higher than that of the Health Care industry. The current valuation for all United States stocks is 70.03% higher than that of the company.
IVERIC Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IVERIC Bio's current stock value. Our valuation model uses many indicators to compare IVERIC Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IVERIC Bio competition to find correlations between indicators driving IVERIC Bio's intrinsic value. More Info.IVERIC Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value IVERIC Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About IVERIC Bio Financial Statements
IVERIC Bio stakeholders use historical fundamental indicators, such as IVERIC Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although IVERIC Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in IVERIC Bio's assets and liabilities are reflected in the revenues and expenses on IVERIC Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IVERIC Bio. Please read more on our technical analysis and fundamental analysis pages.
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases . The company was incorporated in 2007 and is based in Parsippany, New Jersey. Iveric Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |